Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Girerd

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Chest|November 28, 2014
Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2Barbara Girerd, Florence Coulet, Xavier Jaïs, et al.
Circulation|April 6, 2016
Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model"Frédéric Perros, Sven Günther, Benoit Ranchoux, et al.
Circulation|July 2, 2015
Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal ModelsFrédéric Perros, Sven Günther, Benoit Ranchoux, et al.
Oncotarget|September 9, 2017
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertensionAurélie Hautefort, Julie Chesné, Jens Preussner, et al.
Chest|July 26, 2024
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersChristian Gerges, Antoine Beurnier, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|January 15, 2017
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based studyDavid Montani, Barbara Girerd, Xavier Jaïs, et al.
The European Respiratory Journal|December 23, 2018
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult casesMélanie Eyries, David Montani, Sophie Nadaud, et al.
The European Respiratory Journal|November 7, 2015
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive diseaseDavid Montani, Edmund M Lau, Alexis Descatha, et al.
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
Circulation Research|July 27, 2019
Characterization of <i>Kcnk3</i>-Mutated Rat, a Novel Model of Pulmonary HypertensionMélanie Lambert, Véronique Capuano, Angèle Boet, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Chest|November 28, 2014
Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2Barbara Girerd, Florence Coulet, Xavier Jaïs, et al.
Circulation|April 6, 2016
Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model"Frédéric Perros, Sven Günther, Benoit Ranchoux, et al.
Circulation|July 2, 2015
Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal ModelsFrédéric Perros, Sven Günther, Benoit Ranchoux, et al.
Oncotarget|September 9, 2017
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertensionAurélie Hautefort, Julie Chesné, Jens Preussner, et al.
Chest|July 26, 2024
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersChristian Gerges, Antoine Beurnier, Xavier Jaïs, et al.
The Lancet. Respiratory Medicine|January 15, 2017
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based studyDavid Montani, Barbara Girerd, Xavier Jaïs, et al.
The European Respiratory Journal|December 23, 2018
Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult casesMélanie Eyries, David Montani, Sophie Nadaud, et al.
The European Respiratory Journal|November 7, 2015
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive diseaseDavid Montani, Edmund M Lau, Alexis Descatha, et al.
Plos One|October 15, 2013
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertensionLaura C Price, Gaetano Caramori, Frederic Perros, et al.
Circulation Research|July 27, 2019
Characterization of <i>Kcnk3</i>-Mutated Rat, a Novel Model of Pulmonary HypertensionMélanie Lambert, Véronique Capuano, Angèle Boet, et al.
Pageof 10